Del. Jury Finds Kurin Infringed Rival's Blood-Testing Patent
By Dorothy Atkins · July 26, 2022, 9:16 PM EDT
A Delaware federal jury found Tuesday that Kurin Inc.'s blood-testing products infringe Magnolia Medical Technologies Inc.'s blood-testing patent in the first phase of the two-part jury trial, sending the case to...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login